GeNO LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
GeNO LLC (GeNO) is a biopharmaceutical company that offers pulmonary and cardiac disease management solutions. The company offers development of inhaled nitric oxide products for use in hospital setting and for longer-term applications. It provides next-generation drug products which include GeNOsyl Acute DS for use in the hospital setting, and GeNOsyl Chronic DS, a lightweight system that used by patients with chronic diseases. The companys technologies comprise GeNO nitric oxide technology, single-use drug cassette, reactor cartridges, and consoles and controllers. It markets its products across the US. GeNO is headquartered in Cocoa, Florida, the US.
GeNO LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
GeNO LLC (GeNO) is a biopharmaceutical company that offers pulmonary and cardiac disease management solutions. The company offers development of inhaled nitric oxide products for use in hospital setting and for longer-term applications. It provides next-generation drug products which include GeNOsyl Acute DS for use in the hospital setting, and GeNOsyl Chronic DS, a lightweight system that used by patients with chronic diseases. The companys technologies comprise GeNO nitric oxide technology, single-use drug cassette, reactor cartridges, and consoles and controllers. It markets its products across the US. GeNO is headquartered in Cocoa, Florida, the US.
GeNO LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
3
List of Tables 4
List of Figures 4
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GeNO LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
GeNO LLC, Medical Devices Deals, 2011 to YTD 2017 9
GeNO LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
GeNO LLC, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
GeNO Raises US$14.7 Million In Venture Financing 11
Equity Offering 12
GeNO Withdraws IPO for USD50 Million 12
Acquisition 13
The Medicines Company Acquires Minority Stake In GeNO 13
GeNO LLC - Key Competitors 14
GeNO LLC - Key Employees 15
GeNO LLC - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17
List Of Tables
List of TablesGeNO LLC, Pharmaceuticals & Healthcare, Key Facts 2
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GeNO LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GeNO LLC, Deals By Therapy Area, 2011 to YTD 2017 8
GeNO LLC, Medical Devices Deals, 2011 to YTD 2017 9
GeNO LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
GeNO Raises US$14.7 Million In Venture Financing 11
GeNO Withdraws IPO for USD50 Million 12
The Medicines Company Acquires Minority Stake In GeNO 13
GeNO LLC, Key Competitors 14
GeNO LLC, Key Employees 15
GeNO LLC, Other Locations 16
RELATED REPORTS
Acute Myelogenous Leukemia (AML) - Market Insight, Epidemiology and Market Forecast - 2030
Acute Myelogenous Leukemia (AML) - Market Insights, Epidemiology, and Market Forecast-2030 report delivers an in-depth understanding of the Acute Myelogenous Leukemia (AML) , historical and forecasted epidemiology as well
View ReportGlobal Pharmacogenomics (PGX) Market Research Report 2015-2027 of Major Types, Applications and Competitive Vendors in Top Regions and Countries
The Global market for Pharmacogenomics (PGX) is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach USD X.X million in 2027, from
View ReportVisionQuest Biomedical LLC - Product Pipeline Analysis, 2021 Update
VisionQuest Biomedical LLC (VisionQuest) is a medical device company that develops medical imaging tools for the diagnostic services. The companys products include EYESTAR, retinal image quality analyzer, ASPIRE, and diabetic
View ReportEndologix LLC - Strategic SWOT Analysis Review
Endologix LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
